274.26
0.75%
+2.04
United Therapeutics Corp 주식(UTHR)의 최신 뉴스
United Therapeutics (NASDAQ:UTHR) Upgraded at StockNews.com - Defense World
Defense World
UTC Targets Supplier of Liquidia's Lung-Disease Drug Yutrepia - Bloomberg Law
Bloomberg Law
United Therapeutics Co. (NASDAQ:UTHR) Director Christopher Patusky Sells 1310 Shares - Defense World
Defense World
United Therapeutics CEO sells over $1.9m in company stock - Investing.com
Investing.com
Insider Sale: CFO and Treasurer James Edgemond Sells 40,160 Shares of United Therapeutics Corp ... - Yahoo Finance UK
Yahoo Finance UK
United Therapeutics director sells $545,800 in stock By Investing.com - Investing.com Australia
Investing.com Australia
United Therapeutics director sells $545,800 in stock By Investing.com - Investing.com Canada
Investing.com Canada
United Therapeutics CFO sells over $10 million in company stock - Investing.com
Investing.com
United Therapeutics director sells $545,800 in stock By Investing.com - Investing.com
Investing.com
United Therapeutics director sells $545,800 in stock By Investing.com - Investing.com UK
Investing.com UK
Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) CEO Sells 3600 Shares of Stock - Defense World
Defense World
Teacher Retirement System of Texas Cuts Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Defense World
Charles Schwab Investment Management Inc. Raises Stock Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
MarketBeat
MannKind Outperforms As Tyvaso DPI Captures Market Share
Seeking Alpha
United Therapeutics CEO sells over $1.9m in company stock - Investing.com Canada
Investing.com Canada
United Therapeutics CEO sells over $1.9m in company stock - Investing.com Australia
Investing.com Australia
United Therapeutics CEO sells over $1.9m in company stock - Investing.com
Investing.com
United Therapeutics CEO sells over $1.9m in company stock - Investing.com UK
Investing.com UK
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
Zacks Investment Research
International Assets Investment Management LLC Purchases 8,950 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by International Assets Investment Management LLC - Defense World
Defense World
Metis Global Partners LLC Decreases Position in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Defense World
Natixis Advisors L.P. Has $3.53 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Defense World
National Bank of Canada FI Sells 19637 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Defense World
United Therapeutics Co. (NASDAQ:UTHR) CEO Sells $951192.00 in Stock - Defense World
Defense World
United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com Australia
Investing.com Australia
United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com India
Investing.com India
United Therapeutics (NASDAQ:UTHR) Hits New 1-Year High at $268.72 - MarketBeat
MarketBeat
United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com
Investing.com
United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com UK
Investing.com UK
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Zacks Investment Research
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks Investment Research
United Therapeutics Co. (NASDAQ:UTHR) Position Boosted by Fisher Asset Management LLC - Defense World
Defense World
United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com
Investing.com
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks Investment Research
Truist Financial Corp Sells 1505 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Defense World
Victory Capital Management Inc. Buys 101419 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Defense World
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
Zacks Investment Research
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term - Yahoo Canada Finance
Yahoo Canada Finance
United Therapeutics Co. (NASDAQ:UTHR) CEO Sells $934920.00 in Stock - Defense World
Defense World
Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
Zacks Investment Research
Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates
Zacks Investment Research
Best Momentum Stock to Buy for May 7th
Zacks Investment Research
Best Value Stocks to Buy for May 7th
Zacks Investment Research
Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) - Yahoo Finance
Yahoo Finance
Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) - Yahoo Finance
Yahoo Finance
Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) - GuruFocus.com
GuruFocus.com
United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Yahoo Finance
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance
Yahoo Finance
United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run?
Zacks Investment Research
자본화:
|
볼륨(24시간):